News - Headlands Research

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

News

December 8, 2025

December 8, 2025

Frontier Sites in Clinical Trials: Opportunities, Challenges, and Models

Read More

September 16, 2025

September 16, 2025

Combined agonism of nutrient receptors GPR40 and GPR119 with K-757 and K-833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus

Read More

August 19, 2025

August 19, 2025

Headlands Research Opens Twin Cities Clinical Research Site, Extending Upper-Midwest Reach for Sponsors and CROs

Read More

August 14, 2025

August 14, 2025

THL Announces Agreement to Acquire Headlands Research from KKR

Read More

July 2, 2025

July 2, 2025

HEADLANDS RESEARCH INGRESA AL CARIBE CON LA ADQUISICIÓN DE CMRCENTER

Read More

July 2, 2025

July 2, 2025

Headlands Research Enters the Caribbean with Acquisition of CMRCenter

Read More

July 1, 2025

July 1, 2025

Weekly Fixed-Dose Insulin Efsitora in Type 2 Diabetes without Previous Insulin Therapy

Read More

June 24, 2025

June 24, 2025

Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial

Read More

June 23, 2025

June 23, 2025

CagriSema (Cagrilintide–Semaglutide) in Adults with Overweight or Obesity and Type 2 Diabetes

Read More

May 29, 2025

May 29, 2025

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial

Read More

Posts pagination

← 1 2 3 … 7 →

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

© 2026 Headlands Research. | Privacy Policy

Facebook
LinkedIn
Twitter
Instagram